Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 59 min 14 sec ago

FDA Approves Orbera(TM) Bariatric System

Tue, 08/11/2015 - 15:44
Apollo Endosurgery Names Dr. Adam Smith Spokesperson FORT WORTH, Texas, Aug. 11, 2015 -- (Healthcare Sales & Marketing Network) -- The ORBERA™ Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is pr...
Devices, Gastroenterology, Surgery, FDA
Apollo Endosurgery, Orbera, Bariatric System, bariatric surgery

Celgene Receives Antitrust Clearance for Receptos Acquisition

Tue, 08/11/2015 - 15:41
SUMMIT, N.J.--(Healthcare Sales & Marketing Network)--Celgene Corporation (CELG) today announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) with respect to the previously announced tender offer...
Biopharmaceuticals, Mergers & Acquisitions
Celgene, Receptos, Ozanimod

CyMedica Orthopedics(R) Receives CE Mark For The CyMedica QB1(TM) Muscle Activation System

Tue, 08/11/2015 - 15:37
SCOTTSDALE, Ariz., Aug. 11, 2015 -- (Healthcare Sales & Marketing Network) -- CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FD...
Devices, Orthopaedic, Regulatory
CyMedica Orthopedics, QB1, Muscle Activation System

FDA Approves Taro’s Keveyis(TM) (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis

Mon, 08/10/2015 - 19:40
Orphan Drug is First Approved Treatment for Patients Living with Rare Debilitating Disease HAWTHORNE, N.Y.--(Healthcare Sales & Marketing Network)--Taro Pharmaceutical Industries Ltd. (TARO) announced today that the U.S. Food and Drug Administration (F...
Biopharmaceuticals, FDA
Taro Pharmaceutical, Keveyis, dichlorphenamide

Aratana Therapeutics Elects Wendy Yarno as Chairman of the Board of Directors

Mon, 08/10/2015 - 19:37
KANSAS CITY, Kan., Aug. 10, 2015 -- (Healthcare Sales & Marketing Network) -- Aratana Therapeutics, Inc. (PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion ...
Biopharmaceuticals, Personnel
Aratana Therapeutics, Veterinary

Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer

Mon, 08/10/2015 - 19:34
Experienced global commercialization executive to lead Company's launch strategy for oral octreotide capsules NEWTON, Mass. and JERUSALEM, Israel, Aug. 10, 2015 -- (Healthcare Sales & Marketing Network) -- Chiasma, Inc., a U.S. late-stage biopharmaceut...
Biopharmaceuticals, Drug Delivery, Personnel
Chiasma, octreotide, TPE technology

Editas Medicine Raises $120 Million to Advance Genome Editing

Mon, 08/10/2015 - 15:27
Highly Oversubscribed Financing Brings Together World-Class Syndicate to Invest in CRISPR/Cas9 Medicines Proceeds to Expand Editas’ Genome Editing Platform and to Advance Multiple Therapeutic Programs CAMBRIDGE, Mass.--(Healthcare Sales & Marketing N...
Biopharmaceuticals, Venture Capital
Editas Medicine, genomic medicine

Invuity Names James H. Mackaness Chief Financial Officer

Mon, 08/10/2015 - 15:20
SAN FRANCISCO, Aug. 10, 2015 -- (Healthcare Sales & Marketing Network) -- Invuity, Inc. (IVTY), a medical technology company, today announced the appointment of medical device financial and operations executive James H. Mackaness as its Chief Financial Of...
Devices, Surgery, Personnel
Invuity, Intelligent Photonics

Turing Pharmaceuticals Announces $90 Million Series A Financing

Mon, 08/10/2015 - 14:11
Proceeds will be used to invest in developing treatments for serious diseases across a broad range of therapeutic areas NEW YORK, Aug. 10, 2015 -- (Healthcare Sales & Marketing Network) -- Turing Pharmaceuticals AG, a privately-held biopharmaceutical c...
Biopharmaceuticals, Venture Capital
Turing Pharmaceuticals, Syntocinon, Vecamyl

Helix Medical and MedVenture Technology Announce Name Change to Freudenberg Medical

Mon, 08/10/2015 - 14:05
New brand underlines Freudenberg’s clear focus on medical markets CARPINTERIA, Calif.--(Healthcare Sales & Marketing Network)--The Freudenberg Group strengthens its commitment to the medical device and pharmaceutical industries by introducing Freudenber...
Freudenberg Medical, Helix Medical, MedVenture Technology

Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune

Mon, 08/10/2015 - 13:56
Agreement Includes Clinical-Stage INO-3112 HPV Cancer Vaccine and Preclinical Collaboration to Develop Additional Cancer Vaccine Candidates Inovio Schedules Conference Call for 8:30am ET Today; Go to and Click on "Webcast" Tab PL...
Biopharmaceuticals, Licensing
Inovio Pharmaceuticals, MedImmune, AstraZeneca, INO-3112, HPV

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong